Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 3.570
-0.130 (-3.51%)
Jul 11, 2025, 4:25 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 95.89 million as of July 11, 2025. Its market cap has decreased by -62.20% in one year.
Market Cap
95.89M
Enterprise Value
114.32M
Revenue
44.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.57
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 95.89M, a decrease of -85.65%. That is a compound annual growth rate of -35.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 95.89M | 106.54% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.00B |
| Nordhealth AS | 3.01B |
| Photocure ASA | 1.49B |
| Omda AS | 1.09B |
| Vistin Pharma ASA | 1.06B |
| Gentian Diagnostics ASA | 900.67M |
| Thor Medical ASA | 865.49M |
| ArcticZymes Technologies ASA | 863.11M |